Literature DB >> 17958980

Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals.

S Jones1, D de Gijsel, F R Wallach, A C Gurtman, Q Shi, H Sacks.   

Abstract

SETTING: Urban inner city human immunodeficiency virus (HIV) clinic.
OBJECTIVE: To evaluate tuberculin skin testing (TST) and QuantiFERON-TB Gold (QFT-G) testing in an HIV-infected population relative to the presence of risk factors for latent tuberculosis infection (LTBI).
DESIGN: Cross-sectional analysis of the response of a whole blood gamma interferon release assay to early secreted antigenic target 6 (ESAT-6) and culture filtrate protein 10 (CFP-10) antigens and TST relative to known risk factors for LTBI.
RESULTS: Of 207 subjects enrolled, four were excluded due to missing data and three specimens yielded discordant results. Ten specimens were indeterminate due to inadequate response to mitogen. All indeterminate results occurred in subjects with CD(4) counts <200 cells/mm(3). Eleven QFT-G results and 13 TST results were positive. The concordance between TST and QFT-G was poor (kappa 0.38). QFT-G results were more likely than TST to be associated with risk factors for LTBI.
CONCLUSIONS: QFT-G, but not TST, showed a statistically significant association between the number of risk factors for LTBI and a positive result (OR 1.6). QFT-G testing may be more useful than TST in individuals with HIV infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17958980

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  22 in total

Review 1.  Recent advances in testing for latent TB.

Authors:  Neil W Schluger; Joseph Burzynski
Journal:  Chest       Date:  2010-12       Impact factor: 9.410

Review 2.  Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis.

Authors:  Adithya Cattamanchi; Rachel Smith; Karen R Steingart; John Z Metcalfe; Anand Date; Courtney Coleman; Barbara J Marston; Laurence Huang; Philip C Hopewell; Madhukar Pai
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

3.  Interferon-gamma releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrants.

Authors:  G Orlando; S Merli; L Cordier; F Mazza; G Casazza; A M Villa; L Codecasa; E Negri; A Cargnel; M Ferrarese; G Rizzardini
Journal:  Infection       Date:  2010-04-22       Impact factor: 3.553

4.  Performance of QuantiFERON-TB Gold test compared to tuberculin skin test in detecting latent tuberculosis infection in HIV- positive individuals in Iran.

Authors:  Masoud Mardani; Payam Tabarsi; Zohre Mohammadtaheri; Ehsan Chitsaz; Banafsheh Farokhzad; Fatemeh Hadavand; Latif Gachkar; Kambiz Nemati; Mohammad R Masjedi
Journal:  Ann Thorac Med       Date:  2010-01       Impact factor: 2.219

5.  Diagnosis of latent tuberculosis infection among HIV discordant partners using interferon gamma release assays.

Authors:  Naasha J Talati; Esteban Gonzalez-Diaz; Charles Mutemba; Joyanna Wendt; William Kilembe; Lawrence Mwananyanda; Elwyn Chomba; Susan Allen; Carlos del Rio; Henry M Blumberg
Journal:  BMC Infect Dis       Date:  2011-09-30       Impact factor: 3.090

6.  Poor concordance between interferon-gamma release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals.

Authors:  Naasha J Talati; Ulrich Seybold; Bianca Humphrey; Abiola Aina; Jane Tapia; Paul Weinfurter; Rachel Albalak; Henry M Blumberg
Journal:  BMC Infect Dis       Date:  2009-02-10       Impact factor: 3.090

7.  The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis.

Authors:  Martine G Aabye; Pernille Ravn; George PrayGod; Kidola Jeremiah; Apolinary Mugomela; Maria Jepsen; Daniel Faurholt; Nyagosya Range; Henrik Friis; John Changalucha; Aase B Andersen
Journal:  PLoS One       Date:  2009-01-19       Impact factor: 3.240

8.  In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response.

Authors:  Ilaria Sauzullo; Fabio Mengoni; Miriam Lichtner; Anna Paola Massetti; Raffaella Rossi; Marco Iannetta; Raffaella Marocco; Cosmo Del Borgo; Fabrizio Soscia; Vincenzo Vullo; Claudio Maria Mastroianni
Journal:  PLoS One       Date:  2009-04-13       Impact factor: 3.240

9.  Detection of tuberculosis in HIV-infected children using an enzyme-linked immunospot assay.

Authors:  Mary-Ann Davies; Tom Connell; Christine Johannisen; Kathryn Wood; Sandy Pienaar; Katalin A Wilkinson; Robert J Wilkinson; Heather J Zar; Brian Eley; David Beatty; Nigel Curtis; Mark P Nicol
Journal:  AIDS       Date:  2009-05-15       Impact factor: 4.177

10.  Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test.

Authors:  José M Ramos; Catalina Robledano; Mar Masiá; Sofia Belda; Sergio Padilla; Juan C Rodríguez; Félix Gutierrez
Journal:  BMC Infect Dis       Date:  2012-07-31       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.